Safety and Feasibility of Using Sorafenib in Recurrent Hepatocellular Carcinoma after Orthotopic Liver Transplantation

Publisher： Karger

E-ISSN： 1423-0232|79|1-2|62-66

ISSN： 0030-2414

Source： Oncology, Vol.79, Iss.1-2, 2010-11, pp. : 62-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 7, 2015-07 ,pp. : 961-968

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival of children after liver transplantation for hepatocellular carcinoma

By  

LIVER TRANSPLANTATION, Vol. 24, Iss. 2, 2018-02 ,pp. : 246-255

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation

By  

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 895-904

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 2, 2015-02 ,pp. : 187-194

John Wiley & Sons Inc

Access to resources Recommend Favorite

Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation

By  

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 10, 2015-09 ,pp. : 1250-1257

John Wiley & Sons Inc

Access to resources Recommend Favorite